Medicine
ULTOMIRIS 300 mg
Key ingredient(s)
0 Mg
Ravulizumab
Ravulizumab 100
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| CONCENTRATE FOR SOLUTION FOR INFUSION | 100,0 mg | — | Parenteral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2brZKDuPrOP25KWjWA1MxM4gVnpOlkconjyk5VJhDS_wAAPjxZUkAVgMB6pam-_uqv5okeNtntirWi5vKEd6te4xulX_7RsoIVsoebtR2XDsxg | Reg: 59/30.1/0014 | AppNo: 590014 | RegDate: 2025/07/02 | Applicant: AstraZeneca Pharmaceuticals (Pty) Ltd | API: Ravulizumab | Status: Registered